The role of imaging in radiotherapy for Hodgkin lymphoma
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Standard
The role of imaging in radiotherapy for Hodgkin lymphoma. / Hutchings, Martin; Berthelsen, Anne Kiil; Barrington, Sally F.
Radiotherapy for Hodgkin lymphoma. ed. / Lena Specht; Joachim Yahalom. Heidelberg : Springer, 2011. p. 81-89.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - The role of imaging in radiotherapy for Hodgkin lymphoma
AU - Hutchings, Martin
AU - Berthelsen, Anne Kiil
AU - Barrington, Sally F
PY - 2011
Y1 - 2011
N2 - This chapter outlines the increasingly important role of advanced imaging methods in the radiotherapy for Hodgkin lymphoma (HL). CT has become the cornerstone in modern conformal lymphoma radiotherapy. The use of PET/CT before, during and after chemotherapy has an important impact on the selection of early- and advanced-stage patients who receive radiotherapy. PET/CT is more sensitive for HL staging than CT alone, and the method results in upstaging of a significant proportion of patients. Some studies suggest that this may also result in larger radiotherapy volumes. On the other hand, the more precise determination of disease extent can also be used to allow more patient-tailored and less-toxic radiotherapy to the patients.
AB - This chapter outlines the increasingly important role of advanced imaging methods in the radiotherapy for Hodgkin lymphoma (HL). CT has become the cornerstone in modern conformal lymphoma radiotherapy. The use of PET/CT before, during and after chemotherapy has an important impact on the selection of early- and advanced-stage patients who receive radiotherapy. PET/CT is more sensitive for HL staging than CT alone, and the method results in upstaging of a significant proportion of patients. Some studies suggest that this may also result in larger radiotherapy volumes. On the other hand, the more precise determination of disease extent can also be used to allow more patient-tailored and less-toxic radiotherapy to the patients.
U2 - 10.1007/978-3-540-78944-4
DO - 10.1007/978-3-540-78944-4
M3 - Book chapter
SN - 978-3-540-78455-5
SP - 81
EP - 89
BT - Radiotherapy for Hodgkin lymphoma
A2 - Specht, Lena
A2 - Yahalom, Joachim
PB - Springer
CY - Heidelberg
ER -
ID: 34060204